Emphysema or COPD Clinical Trials

12 recruiting

Frequently Asked Questions

Common questions about Emphysema or COPD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Emphysema or COPDEmphysema, Pulmonary
Pulmonx Corporation200 enrolled36 locationsNCT06035120
Recruiting

PiMZ Longitudinal Cohort (PiMZ Logic)

Alpha 1-Antitrypsin DeficiencyEmphysema or COPD
Columbia University80 enrolled5 locationsNCT06505603
Recruiting
Phase 1Phase 2

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Idiopathic Pulmonary FibrosisEmphysema or COPD
Paul Szabolcs8 enrolled2 locationsNCT03500731
Recruiting
Not Applicable

Ultrasound and Respiratory Physiological Signals in Lung Diseases

UltrasoundChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS25 enrolled1 locationNCT06068647
Recruiting
Not Applicable

Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction

Emphysema or COPD
Beth Israel Deaconess Medical Center20 enrolled1 locationNCT05257681
Recruiting
Not Applicable

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema

Emphysema or COPD
Beth Israel Deaconess Medical Center20 enrolled1 locationNCT04801108
Recruiting
Not Applicable

The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

COPDEmphysemaCOPD, Chronic Obstructive Pulmonary Disease+2 more
Morair Medtech, LLC30 enrolled7 locationsNCT06655428
Recruiting

Post-Market BTVA Registry

Emphysema or COPD
Uptake Medical Technology, Inc.300 enrolled20 locationsNCT03318406
Recruiting
Not Applicable

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

COPDInterstitial Lung DiseasePulmonary Fibrosis+7 more
MGH Institute of Health Professions30 enrolled1 locationNCT06304207
Recruiting

Biological Investigation of Explanted Endobronchial Lung Valves Study

Emphysema or COPD
University Medical Center Groningen150 enrolled1 locationNCT04214587
Recruiting
Early Phase 1

Airway Bypass - Safety and Feasibility Study

Emphysema or COPD
Zoar Engelman10 enrolled1 locationNCT06249529
Recruiting

The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility

Chronic Obstructive Pulmonary DiseaseEmphysema or COPD
Aarhus University Hospital35 enrolled1 locationNCT06163131